Articles tagged with: EU Pharmaceutical Strategy
This week in the European Parliament
11 Oct
This week in the European Parliament
The European Parliament’s Committees and Political Groups will be meeting in Brussels this week with important decisions due on both fronts, and against the background of a Rule of Law crisis triggered by the Polish Constitutional Tribunal ruling against the primacy of EU law on Friday
Nanomedicines and Nanosimilars: Building a robust legislative framework Partner Content
26 Jul
Nanomedicines and Nanosimilars: Building a robust legislative framework
The EU has the chance to lead the world in developing a centralised regulatory procedure for nanomedicines and nanosimilars, argues Petar Vitanov
Making Europe a life sciences leader Partner Content
07 Jul
Making Europe a life sciences leader
EFPIA’s new board leadership team aims to combat COVID-19 and tackle societal challenges in order to make Europe a life sciences leader, writes Hubertus von Baumbach.
Rebuilding trust in science Partner Content
07 Jul
Rebuilding trust in science
The current pandemic has shown the importance of science; however, tackling future challenges requires a relationship based on trust between scientists and society, argues MEP Ivars Ijabs.
Health & Wellbeing: Securing the future for health
06 Jul
Health & Wellbeing: Securing the future for health
Now is the time to establish a new and better strategy for healthcare that future-proofs supplies of medicines and medical goods, writes Tomislav Sokol.
How do we solve the rare disease crisis? Partner Content
27 May
How do we solve the rare disease crisis?
Pfizer often made the headlines over the past year after mobilising their scientific expertise and manufacturing capabilities to respond to the COVID-19 pandemic. Reda Guiha, Regional President for Rare Disease at Pfizer, argues that the same sense of urgency and public-private sector collaboration that brought vaccines to patients within a year should be applied to other areas of critical unmet medical need, such as rare disease.
Why waiving patents on vaccines is not a good idea
14 May
Why waiving patents on vaccines is not a good idea
Although noble in intent, the decision could ultimately undermine Europe’s leadership in pharmaceutical research, argues Gianna Gancia.
Time to overhaul the patent protection law
07 Apr
Time to overhaul the patent protection law
While the current health crisis has wreaked havoc in many sectors, in pharmaceuticals it is the EU’s patent law that is hampering innovation and access to medicines, explains Katerina Konecná.
Issue 533 | 29 March 2021
29 Mar
Issue 533 | 29 March 2021
Gracing this issue’s cover is Romanian Renew Europe deputy Vlad Gheorghe, who was a just toddler when Romania’s 50-year experiment with Communism came crashing down in December 1989. He explains to editor Brian Johnson how the country’s integration back into the EU fold has been a major factor in shaping his politics and worldview.
The pharmaceutical industry can be the catalyst for a sustainable and resilient healthcare system in Greece Partner Content
03 Feb
The pharmaceutical industry can be the catalyst for a sustainable and resilient healthcare system in Greece
SFEE and its member companies are committed to ensuring the sustainability of our healthcare systems by breaking barriers and silos and working together with policymakers to deliver outcomes to patients, society and the national economy, writes Olympios Papadimitriou.
EU Pharma Strategy too focussed on needs of manufacturers, rather than patients, says Michèle Rivasi
09 Dec
EU Pharma Strategy too focussed on needs of manufacturers, rather than patients, says Michèle Rivasi
Greens/EFA MEP says European Commission’s long overdue pharmaceutical strategy ‘fails to address’ EU’s true health problems, including drug shortages.
Post COVID-19, is it time for a genuine European Health Union?
09 Dec
Post COVID-19, is it time for a genuine European Health Union?
Recent events have shown that Member States struggle to deal with supranational threats such as the current Coronavirus crisis; it’s time to look at a Health Union, writes Alessandra Moretti.
Why the EU needs pharmaceutical independence
10 Jul
Why the EU needs pharmaceutical independence
The Coronavirus outbreak has shown why the EU must address medical shortages and re-establish its position as a world leader in the pharmaceutical field, argues Tomislav Sokol.
EU Pharmaceutical Strategy could be a lost opportunity if action is not taken now Partner Content
02 Jul
EU Pharmaceutical Strategy could be a lost opportunity if action is not taken now
In its current form, the pharma strategy roadmap lacks the necessary drivers of innovation to put Europe back at the forefront of medical discovery, writes Nathalie Moll